...
首页> 外文期刊>Bulletin of Faculty of Pharmacy, Cairo University >Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection
【24h】

Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection

机译:成膜伏立康唑透皮喷雾剂治疗真菌感染的制备与表征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Voriconazole is second-generation triazole used for the treatment of fungal infections but has serious unwanted adverse effects, which could be reduced by topical semisolid dosage form. Major drawbacks of topical semisolid products are poor patient compliance, cross contamination; gels are easily rubbed off by clothing and during day-to-day activities, physical instability. The purpose of the present work was to fabricate 0.5% w/w voriconazole transdermal spray for fungal infection. The transdermal spray was generated by using a film forming polymers like Eudragit RLPO and ethyl cellulose (1:2 ratios) along with eutectic camphor: menthol (1:1) mixture used as a penetration enhancer. The formulation optimized by constrained 3 2 factorial design. Regression analysis and response surface methodology were used to optimize the effect of polymers and formulate checkpoint batch based on overlay plots. The transdermal spray was subjected to evaluate parameters related to formulation and containers. The concentration of Eudragit RLPO and ethyl cellulose was showed influence on viscosity as well as t 50 . Diffusion study was showed 75% of voriconazole transport with 65.8 μgcm ?2 h ?1 fluxes. Penetration enhancers’ had shown an increase in 1.68 fold of the penetration of voriconazole through the formulation. The study was concluded that fabricated film forming voriconazole transdermal spray formulations penetrate to the deep layer of the skin and was feasible to treat the dermatological fungal infection. This delivery platform is opened a wide range of treatment of fungal infection as compared to conventional formulations.
机译:伏立康唑是用于治疗真菌感染的第二代三唑,但具有严重的不良副作用,可通过局部半固体剂型减轻。局部半固体产品的主要缺点是患者依从性差,交叉污染。凝胶很容易被衣物擦掉,并且在日常活动中身体不稳。本工作的目的是制造用于真菌感染的0.5%w / w伏立康唑透皮喷雾剂。通过使用成膜聚合物(例如Eudragit RLPO和乙基纤维素(1:2的比例))以及用作渗透促进剂的共晶樟脑:薄荷醇(1:1)混合物产生透皮喷雾。通过约束3 2因子设计优化了配方。回归分析和响应面方法被用于优化聚合物的效果,并基于覆盖图制定检查点批次。使经皮喷雾剂评估与制剂和容器有关的参数。显示Eudragit RLPO和乙基纤维素的浓度对粘度以及t 50有影响。扩散研究表明伏立康唑的传输率为75.8%,通量为65.8μgcm?2 h?1。渗透促进剂显示伏立康唑通过制剂的渗透增加了1.68倍。研究得出结论,伏立康唑制成的成膜成膜透皮喷雾剂可渗透到皮肤深层,可用于治疗皮肤真菌感染。与常规制剂相比,该递送平台为真菌感染的治疗提供了广阔的范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号